No photo of Elisabeth M. Paietta

View Scopus Profile

Elisabeth M. Paietta, Ph.D.

  • 19006 Citations
  • 68 h-Index
1974 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Elisabeth M. Paietta is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles
Acute Myeloid Leukemia Medicine & Life Sciences
Precursor Cell Lymphoblastic Leukemia-Lymphoma Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Acute Promyelocytic Leukemia Medicine & Life Sciences
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Blast Crisis Medicine & Life Sciences
Cytarabine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2014 2019

ECOG-ACRIN INTEGRATED LEUKEMIA TRANSLATIONAL RESEARCH CENTER

Paietta, E. M., Levine, R., Melnick, A. M. & Melnick, A. M.

National Institutes of Health

4/14/14 → 2/28/19

Project: Research project

Translational Medical Research
Leukemia
Tissue Banks
Clinical Trials
Genomics

Publications 1974 2019

13 Citations (Scopus)

A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403

Stock, W., Luger, S. M., Advani, A. S., Yin, J., Harvey, R. C., Mullighan, C. G., Willman, C. L., Fulton, N., Laumann, K. M., Malnassy, G., Paietta, E. M., Parker, E., Geyer, S., Mrózek, K., Bloomfield, C. D., Sanford, B., Marcucci, G., Liedtke, M., Claxton, D. F., Foster, M. C. & 8 others, Bogart, J. A., Grecula, J. C., Appelbaum, F. R., Erba, H., Litzow, M. R., Tallman, M. S., Stone, R. M. & Larson, R. A., Apr 4 2019, In : Blood. 133, 14, p. 1548-1559 12 p.

Research output: Contribution to journal › Article

Pediatrics
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Young Adult
Confidence Intervals
Disease-Free Survival

Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900

Fernandez, H. F., Sun, Z., Litzow, M. R., Luger, S. M., Paietta, E. M., Racevskis, J., Levine, R. L., Patel, J. P., Abdel-Wahab, O., Ketterling, R. P., Dewald, G. W., Bennett, J. M., Rowe, J. M., Lazarus, H. M. & Tallman, M. S., Apr 1 2019, In : Haematologica. 104, 4, p. e147-e150

Research output: Contribution to journal › Letter

Open Access
Anthracyclines
Acute Myeloid Leukemia
Young Adult

Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab

Erbe, A. K., Wang, W., Carmichael, L., Hoefges, A., Grzywacz, B., Reville, P. K., Ranheim, E. A., Hank, J. A., Kim, K. M., Seo, S., Mendonca, E. A., Song, Y., Kenkre, V. P., Hong, F., Gascoyne, R. D., Paietta, E. M., Horning, S. J., Miller, J. S., Kahl, B. & Sondel, P. M., Mar 12 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 70.

Research output: Contribution to journal › Article

Open Access
KIR Receptors
Follicular Lymphoma
Ligands
Genotype
Natural Killer Cells
8 Citations (Scopus)

PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia

Gu, Z., Churchman, M. L., Roberts, K. G., Moore, I., Zhou, X., Nakitandwe, J., Hagiwara, K., Pelletier, S., Gingras, S., Berns, H., Payne-Turner, D., Hill, A., Iacobucci, I., Shi, L., Pounds, S., Cheng, C., Pei, D., Qu, C., Newman, S., Devidas, M. & 40 others, Dai, Y., Reshmi, S. C., Gastier-Foster, J., Raetz, E. A., Borowitz, M. J., Wood, B. L., Carroll, W. L., Zweidler-McKay, P. A., Rabin, K. R., Mattano, L. A., Maloney, K. W., Rambaldi, A., Spinelli, O., Radich, J. P., Minden, M. D., Rowe, J. M., Luger, S., Litzow, M. R., Tallman, M. S., Racevskis, J., Zhang, Y., Bhatia, R., Kohlschmidt, J., Mrózek, K., Bloomfield, C. D., Stock, W., Kornblau, S., Kantarjian, H. M., Konopleva, M., Evans, W. E., Jeha, S., Pui, C. H., Yang, J., Paietta, E. M., Downing, J. R., Relling, M. V., Zhang, J., Loh, M. L., Hunger, S. P. & Mullighan, C. G., Feb 1 2019, In : Nature Genetics. 51, 2, p. 296-307 12 p.

Research output: Contribution to journal › Article

Precursor Cell Lymphoblastic Leukemia-Lymphoma
PAX5 Transcription Factor
Mutation
Transcriptome
Genes

Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903)

Kempin, S., Sun, Z., Kay, N. E., Paietta, E. M., Mazza, J. J., Ketterling, R. P., Frankfurt, O., Claxton, D. F., Saltzman, J. N., Srkalovic, G., Callander, N. S., Gross, G. & Tallman, M. S., Jan 1 2019, In : Acta Haematologica.

Research output: Contribution to journal › Article

Pentostatin
B-Cell Chronic Lymphocytic Leukemia
Cyclophosphamide
Research
Neoplasms